Momenta

Press Releases

All Releases
View Summary Momenta Pharmaceuticals' Necuparanib Receives Fast Track Designation From the FDA for the Treatment of Patients With Metastatic Pancreatic Cancer
Dec 1, 2014
PDF 11.1 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Acceptance of a Clinical Trial Application in Europe for M923, a Biosimilar Version of Humira(R)
Dec 1, 2014
PDF 10.7 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at 2014 Deutsche Bank BioFEST
Nov 24, 2014
PDF 7.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences
Nov 6, 2014
PDF 7.5 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports Third Quarter 2014 Financial Results
Nov 5, 2014
PDF 24.1 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of Third Quarter 2014 Financial Results Conference Call and Webcast
Oct 22, 2014
PDF 7.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Top-Line Part A Results From Phase 1/2 Trial of Necuparanib in Patients With Pancreatic Cancer
Oct 9, 2014
PDF 57.7 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Host 2014 R&D Day
Oct 2, 2014
PDF 9.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at BioCentury's NewsMakers in the Biotech Industry Conference
Sep 17, 2014
PDF 7.1 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibodies From AnaptysBio
Sep 8, 2014
PDF 10.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Abbreviated New Drug Application for Three-Times-a-Week Generic Copaxone Accepted for Review by FDA
Aug 28, 2014
PDF 10.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports Second Quarter 2014 Financial Results
Jul 31, 2014
PDF 21.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at the Canaccord Genuity Growth Conference
Jul 30, 2014
PDF 6.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of Second Quarter 2014 Financial Results Conference Call and Webcast
Jul 15, 2014
PDF 7.3 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at the Wells Fargo Healthcare Conference
Jun 9, 2014
PDF 6.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Receives Orphan Drug Designation for Necuparanib (Formerly M402) in Pancreatic Cancer
Jun 5, 2014
PDF 10.3 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports First Quarter 2014 Financial Results
May 6, 2014
PDF 22.3 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Presentation of Data Supporting Sialylation Platform
May 2, 2014
PDF 9.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences
Apr 30, 2014
PDF 7.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of First Quarter 2014 Financial Results Conference Call and Webcast
Apr 15, 2014
PDF 7.3 KB Add to Briefcase
Showing 1-20 of 315 Page: 1 2 3 4 5 ... 16  Next 20
Add to Briefcase = add release to Briefcase